Literature DB >> 22825252

Reconciling the different roles of Gsk3β in "naïve" and "primed" pluripotent stem cells.

Amar M Singh1, Matthew Bechard, Keriayn Smith, Stephen Dalton.   

Abstract

Signaling pathways orchestrated by PI3K/Akt, Raf/Mek/Erk and Wnt/β-catenin are known to play key roles in the self-renewal and differentiation of pluripotent stem cells. The serine/threonine protein kinase Gsk3β has roles in all three pathways, making its exact function difficult to decipher. Consequently, conflicting reports have implicated Gsk3β in promoting self-renewal, while others suggest that it performs roles in the activation of differentiation pathways. Different thresholds of Gsk3β activity also have different biological effects on pluripotent cells, making this situation even more complex. Here, we describe a further level of complexity that is most apparent when comparing "naïve" murine and "primed" human pluripotent stem cells. In naïve cells, Gsk3β activity is restrained by PI3K/Akt, but when released from inhibitory signals it antagonizes self-renewal pathways by targeting pluripotency factors such as Myc and Nanog. This situation also applies in primed cells, but, in addition, a separate pool of Gsk3β is required to suppress canonical Wnt signaling. These observations suggest that different Gsk3β-protein complexes shift the balance between naïve and primed pluripotent cells and identify fundamental differences in their cell signaling. Altogether, these findings have important implications for the mechanisms underpinning the establishment of different pluripotent cell states and for the control of self-renewal and differentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825252      PMCID: PMC3442909          DOI: 10.4161/cc.21110

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

1.  Efficient differentiation of human embryonic stem cells to definitive endoderm.

Authors:  Kevin A D'Amour; Alan D Agulnick; Susan Eliazer; Olivia G Kelly; Evert Kroon; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2005-10-28       Impact factor: 54.908

Review 2.  beta-catenin destruction complex: insights and questions from a structural perspective.

Authors:  D Kimelman; W Xu
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

3.  Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed.

Authors:  Amanda B McLean; Kevin A D'Amour; Karen L Jones; Malini Krishnamoorthy; Michael J Kulik; David M Reynolds; Alan M Sheppard; Huiqing Liu; Ying Xu; Emmanuel E Baetge; Stephen Dalton
Journal:  Stem Cells       Date:  2007-01       Impact factor: 6.277

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling.

Authors:  Linlin Wang; Thomas C Schulz; Eric S Sherrer; Derek S Dauphin; Soojung Shin; Angelique M Nelson; Carol B Ware; Mei Zhan; Chao-Zhong Song; Xiaoji Chen; Sandii N Brimble; Amanda McLean; Maria J Galeano; Elizabeth W Uhl; Kevin A D'Amour; Jonathan D Chesnut; Mahendra S Rao; C Anthony Blau; Allan J Robins
Journal:  Blood       Date:  2007-08-29       Impact factor: 22.113

6.  Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling.

Authors:  Nicholas R D Paling; Helen Wheadon; Heather K Bone; Melanie J Welham
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

7.  New cell lines from mouse epiblast share defining features with human embryonic stem cells.

Authors:  Paul J Tesar; Josh G Chenoweth; Frances A Brook; Timothy J Davies; Edward P Evans; David L Mack; Richard L Gardner; Ronald D G McKay
Journal:  Nature       Date:  2007-06-27       Impact factor: 49.962

8.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

9.  Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells.

Authors:  Mike P Storm; Heather K Bone; Craig G Beck; Pierre-Yves Bourillot; Valerie Schreiber; Teresa Damiano; Adam Nelson; Pierre Savatier; Melanie J Welham
Journal:  J Biol Chem       Date:  2007-01-04       Impact factor: 5.157

10.  Derivation of pluripotent epiblast stem cells from mammalian embryos.

Authors:  I Gabrielle M Brons; Lucy E Smithers; Matthew W B Trotter; Peter Rugg-Gunn; Bowen Sun; Susana M Chuva de Sousa Lopes; Sarah K Howlett; Amanda Clarkson; Lars Ahrlund-Richter; Roger A Pedersen; Ludovic Vallier
Journal:  Nature       Date:  2007-06-27       Impact factor: 49.962

View more
  12 in total

1.  Protein kinase C-induced early growth response protein-1 binding to SNAIL promoter in epithelial-mesenchymal transition of human embryonic stem cells.

Authors:  Masaki Kinehara; Suguru Kawamura; Sumiyo Mimura; Mika Suga; Akiko Hamada; Mari Wakabayashi; Hiroki Nikawa; Miho K Furue
Journal:  Stem Cells Dev       Date:  2014-02-24       Impact factor: 3.272

Review 2.  Signaling networks in human pluripotent stem cells.

Authors:  Stephen Dalton
Journal:  Curr Opin Cell Biol       Date:  2012-10-22       Impact factor: 8.382

Review 3.  Directed differentiation of pluripotent stem cells to kidney cells.

Authors:  Albert Q Lam; Benjamin S Freedman; Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2014-06-13       Impact factor: 5.299

Review 4.  Cell Cycle-Driven Heterogeneity: On the Road to Demystifying the Transitions between "Poised" and "Restricted" Pluripotent Cell States.

Authors:  Amar M Singh
Journal:  Stem Cells Int       Date:  2015-04-05       Impact factor: 5.443

Review 5.  Molecular mechanisms of induced pluripotency.

Authors:  Katarzyna Kulcenty; Joanna Wróblewska; Sylwia Mazurek; Ewa Liszewska; Jacek Jaworski
Journal:  Contemp Oncol (Pozn)       Date:  2015

6.  CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency.

Authors:  Xiao Qi Wang; Chung Mau Lo; Lin Chen; Elly S-W Ngan; Aimin Xu; Randy Yc Poon
Journal:  Cell Death Differ       Date:  2016-09-16       Impact factor: 15.828

7.  Direct comparison of distinct naive pluripotent states in human embryonic stem cells.

Authors:  S Warrier; M Van der Jeught; G Duggal; L Tilleman; E Sutherland; J Taelman; M Popovic; S Lierman; S Chuva De Sousa Lopes; A Van Soom; L Peelman; F Van Nieuwerburgh; D I M De Coninck; B Menten; P Mestdagh; J Van de Sompele; D Deforce; P De Sutter; B Heindryckx
Journal:  Nat Commun       Date:  2017-04-21       Impact factor: 14.919

Review 8.  PI3K in stemness regulation: from development to cancer.

Authors:  Ralitsa R Madsen
Journal:  Biochem Soc Trans       Date:  2020-02-28       Impact factor: 5.407

9.  Efficient reprogramming of naïve-like induced pluripotent stem cells from porcine adipose-derived stem cells with a feeder-independent and serum-free system.

Authors:  Yu Zhang; Chao Wei; Pengfei Zhang; Xia Li; Tong Liu; Yong Pu; Yunsheng Li; Zubing Cao; Hongguo Cao; Ya Liu; Xiaorong Zhang; Yunhai Zhang
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

Review 10.  GSK-3 as potential target for therapeutic intervention in cancer.

Authors:  James A McCubrey; Linda S Steelman; Fred E Bertrand; Nicole M Davis; Melissa Sokolosky; Steve L Abrams; Giuseppe Montalto; Antonino B D'Assoro; Massimo Libra; Ferdinando Nicoletti; Roberta Maestro; Jorg Basecke; Dariusz Rakus; Agnieszka Gizak; Zoya N Demidenko; Lucio Cocco; Alberto M Martelli; Melchiorre Cervello
Journal:  Oncotarget       Date:  2014-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.